BridgeMD
New treatment option for Cataract
Official title Comparison of Two Non- Diffractive Extended Depth of Focus Intraocular Lenses
ClinicalTrials.gov ID: NCT06607848
What this study is testing
- What it's testing
- Intra-individual comparison of the PureSee EDOF IOL with the Acunex Vario EDOF IOL set for emmetropia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 105
You may be able to join if
- Age-related bilateral cataract
- Age 21 or older
- Visual acuity \> 0.05
- For patients with regular corneal astigmatism greater than or equal to 1.00 dpt toric IOLs will be implanted
- Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically relevant
You likely can't join if
- Active ocular disease (e.g chronic uveitis, diabetic retinopathy, chronic glaucoma not responsive to medication, corneal dystrophies, etc.)...
- Relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX)
- Corneal decompensation or corneal endothelial cell insufficiency
- Irregular astigmatism on corneal tomography
- Pronounced dry eye disease
- Previous ocular surgery or trauma
See the full eligibility criteria
- Age-related bilateral cataract
- Age 21 or older
- Visual acuity \> 0.05
- For patients with regular corneal astigmatism greater than or equal to 1.00 dpt toric IOLs will be implanted
- Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically relevant
- Written informed consent prior to surgery
- Active ocular disease (e.g chronic uveitis, diabetic retinopathy, chronic glaucoma not responsive to medication, corneal dystrophies, etc.) precluding good post-operative visual acuity
- Relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX)
- Corneal decompensation or corneal endothelial cell insufficiency
- Irregular astigmatism on corneal tomography
- Pronounced dry eye disease
- Previous ocular surgery or trauma
- Persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age)
The study team makes the final eligibility decision.
Where it's taking place
- Vienna, Austria, Austria
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 105 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vienna, Austria, Austria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.